Complete Care At Brackenville Llc
COMPLETE CARE AT BRACKENVILLE LLC in HOCKESSIN, DE — inspection on September 15, 2025.
Found 3 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
Based on record review and interview, it was determined that for one (R2) out of three residents sampled for care plans, the facility failed to develop a person-centered care plan for the refusal of medications.
Findings include:6/27/25 - R2 was admitted to the facility with diagnoses including but not limited to muscle weakness, bladder cancer and ocular myasthenia gravis. R2's admission medications included pyridostigmine bromide oral tablet 60 mg two times a day for the treatment of ocular myasthenia gravis.7/1/25 - R2's clinical records documented a BIMS score of 15, indicating a completely cognitive intact status.6/28/25 - 7/22/25 - R2's clinical records documented twenty-eight (28) episodes of refusal of pyridostigmine bromide tablets out of forty-nine (49) opportunities.9/12/25 11:30 AM - A review of R2's clinical records lacked evidence of a care plan for the refusal of medications.9/12/25 1:00 PM - During an interview, finding was confirmed with E2 (DON).9/15/25 3:15 PM - Findings were reviewed during the exit conference with E1 (NHA), E2 (DON) and E3 (RN).
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided.
For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE
TITLE
Facility ID:
IDENTIFICATION NUMBER:
A.
Building
COMPLETED
09/15/2025
STREET ADDRESS, CITY, STATE, ZIP CODE
Complete Care at Brackenville LLC
100 St.
Claire Drive Hockessin, DE 19707
SUMMARY STATEMENT OF DEFICIENCIES
accepting medications from the pharmacy. E2 stated, The nurse must sign for any narcotics. If the iv medications must be refrigerated, they are put in the fridge and checked before they are administered.
The pills are checked before they are put on the medication carts.
The facility failed to ensure that R5's iv medication was administered according to accepted standards of clinical practice.9/12/25 2:30 PM - During an interview, finding was confirmed with E2 (DON). 9/15/25 3:15 PM - Findings were reviewed during the exit conference with E1 (NHA), E2 (DON) and E3 (RN).
Facility ID:
IDENTIFICATION NUMBER:
A.
Building
COMPLETED
09/15/2025
STREET ADDRESS, CITY, STATE, ZIP CODE
Complete Care at Brackenville LLC
100 St.
Claire Drive Hockessin, DE 19707
SUMMARY STATEMENT OF DEFICIENCIES
they administered 850mg of daptomycin instead of 800mg for two or three doses. 9/12/25 2:30 PM - During an interview, finding was confirmed with E2 (DON). 9/15/25 3:15 PM - Findings were reviewed during the exit conference with E1 (NHA), E2 (DON) and E3 (RN).
Facility ID: